117th Congress · HOUSE BILLBILL

H.R. 7515 — Infectious Disease Therapies Research and Innovation Act of 2022

“To amend the Internal Revenue Code of 1986 to provide an exception from the passive loss rules for investments in specified medical research small business pass-thru entities.”

Taxation

Introduced Apr 14, 2022

Last action Apr 14, 2022

Pipeline · Bill → Law

Step 1

Introduced

Apr 14, 2022

Step 2

Referred

Apr 14, 2022

Ways & Means

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 2 actions

Apr 14, 2022

Introduced in House

Apr 14, 2022

Referred to the House Committee on Ways and Means.